[1]
“ Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2 ”, Clinics, vol. 61, no. 1, pp. 59–70, Feb. 2006, doi: 10.1590/S1807-59322006000100011.